Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ICI-204,219

Known as: ICI 204,219, ICI 204219, ICI-204219 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1995
Highly Cited
1995
The efficacy and safety of single oral doses of the leukotriene D4-receptor antagonist, ICI 204,219, were tested in subjects with… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The efficacy of 6 wk of therapy with oral ICI 204,219, a selective leukotriene D4 (LTD4) receptor antagonist, was evaluated in… Expand
Is this relevant?
1994
1994
The hypothesis that cysteinyl-leukotrienes (LTC4, LTD4 and LTE4) are mediators of allergen-induced airway obstruction in… Expand
Is this relevant?
1993
1993
Leukotrienes are potent bronchoconstrictors, and they are present in the airways of asthmatic subjects. Leukotriene receptor… Expand
Is this relevant?
1993
1993
ICI 204,219 is a potent and specific leukotriene D4 receptor antagonist that blocks both the early and late responses to allergen… Expand
Is this relevant?
1993
1993
We determined whether platelet-activating factor (PAF) caused bronchoconstriction through the release of leukotrienes (LT) by… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The sulfidopeptide leukotrienes C4, D4, and E4 are released from mast cells in response to allergen challenge and may be involved… Expand
Is this relevant?
1992
1992
We studied the effect of a single oral dose of ICI 204,219 on subject response to bronchoprovocation and quantitative skin… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
In vivo production of thromboxane (TX) A2 and the cysteinyl-containing leukotrienes (LT) C4, D4, and E4 in correlation to airway… Expand
Is this relevant?
1990
1990
ICI 204,219 (4-(5-cyclopentyloxycarbonylamino-1-methylindol-3-ylmethy l)-3- methoxy-N-o-tolylsulfonylbenzamide) was designed as a… Expand
Is this relevant?